Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients ◽

Aspirin and Clopidogrel Compared With Clopidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial

Yearbook of Vascular Surgery ◽

10.1016/s0749-4041(08)70222-7 ◽

2006 ◽

Vol 2006 ◽

pp. 289-290

Author(s):

G.L. Moneta

Keyword(s):

High Risk ◽

Ischaemic Stroke ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients ◽

Aspirin and Clopidogrel Compared With Clopidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(08)70251-5 ◽

2006 ◽

Vol 2006 ◽

pp. 28-30

Author(s):

A.A. Rabinstein

Keyword(s):

High Risk ◽

Ischaemic Stroke ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients ◽

Management of Atherothrombosis with Clopidogrel in High-Risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke (MATCH): Study Design and Baseline Data

Cerebrovascular Diseases ◽

10.1159/000076962 ◽

2003 ◽

Vol 17 (2-3) ◽

pp. 253-261 ◽

Cited By ~ 47

Author(s):

Hans-Christoph Diener ◽

Julien Bogousslavsky ◽

Lawrence M. Brass ◽

Claudio Cimminiello ◽

Laszlo Csiba ◽

...

Keyword(s):

High Risk ◽

Ischaemic Stroke ◽

Study Design ◽

Baseline Data ◽

High Risk Patients ◽

Risk Patients ◽

Aprepitant, a Neurokinin-1 Receptor Antagonist, for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Randomized, Double-blind, Placebo Controlled Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201110002-00133 ◽

2011 ◽

Vol 106 ◽

pp. S54

Author(s):

Tilak Shah ◽

Martin Poleski ◽

Stanley Branch ◽

Paul Jowell ◽

Jorge Obando ◽

...

Keyword(s):

High Risk ◽

Receptor Antagonist ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Neurokinin 1 Receptor ◽

High Risk Patients ◽

Risk Patients ◽

Neurokinin 1

Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): Randomized, double-blind, placebo-controlled trial

ACC Current Journal Review ◽

10.1016/j.accreview.2004.08.105 ◽

2004 ◽

Vol 13 (10) ◽

pp. 17

Author(s):

H.C. Diener ◽

J. Bogousslavsky ◽

L.M. Brass

Keyword(s):

Ischemic Stroke ◽

High Risk ◽

Transient Ischemic Attack ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients ◽

Ischemic Attack

Aspirin plus clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in patients at high risk patients (MATCH): Randomized double-blind placebo-controlled trial

Journal of Vascular Surgery ◽

10.1016/j.jvs.2004.10.007 ◽

2004 ◽

Vol 40 (6) ◽

pp. 1259

Author(s):

D Hans-Christoph ◽

J Bogousslavsky ◽

LM Brass

Keyword(s):

Ischemic Stroke ◽

High Risk ◽

Transient Ischemic Attack ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients ◽

Ischemic Attack

Randomized, Double-blind, Placebo-controlled Trial of Atenolol for the Prevention of Perioperative Myocardial Ischemia in High-risk Patients Scheduled for Noncardiac Surgery

Anesthesiology ◽

10.1097/00000542-199409001-00099 ◽

1994 ◽

Vol 81 (SUPPLEMENT) ◽

pp. A100 ◽

Cited By ~ 1

Author(s):

A. Wallace ◽

E. Layug ◽

W. Browner ◽

M. Hollenberg ◽

U. Jain ◽

...

Keyword(s):

High Risk ◽

Myocardial Ischemia ◽

Controlled Trial ◽

Noncardiac Surgery ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients

Faculty Opinions recommendation of Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735810391.793560626 ◽

2019 ◽

Author(s):

Eric Hoste

Keyword(s):

Randomized Controlled Trial ◽

High Risk ◽

Controlled Trial ◽

Contrast Induced Nephropathy ◽

Double Blind ◽

High Risk Patients ◽

Randomized Controlled ◽

Risk Patients

A Phase II Multicenter Double-Blind Placebo-Controlled Study of Ethyl Pyruvate in High-Risk Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Journal of Cardiothoracic and Vascular Anesthesia ◽

10.1053/j.jvca.2008.08.005 ◽

2009 ◽

Vol 23 (3) ◽

pp. 324-329 ◽

Cited By ~ 52

Author(s):

Elliott Bennett-Guerrero ◽

Madhav Swaminathan ◽

Alina M. Grigore ◽

Gary W. Roach ◽

Laura G. Aberle ◽

...

Keyword(s):

Cardiac Surgery ◽

Cardiopulmonary Bypass ◽

High Risk ◽

Phase Ii ◽

Ethyl Pyruvate ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Patients ◽

Risk Patients

A 52 week double blind randomised controlled trial comparing the effect of rosiglitazone versus placebo on the prevention of progression of atherosclerosis in high risk patients without diabetes

http://isrctn.org/> ◽

10.1186/isrctn54951661 ◽

2013 ◽

Author(s):

R. Alizadeh Dehnavi

Keyword(s):

High Risk ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Double Blind ◽

High Risk Patients ◽

Risk Patients ◽

Randomised Controlled ◽

Progression Of Atherosclerosis